Sanofi, a global health care company, recently signed an agreement with the University of Texas System to fund selected research programs focused on the early stages of drug discovery.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.